Overview Live Pharmaceutical Webinars and Webinar Recordings
Next Live Webinars
ExciPerience 2023
The third ExciPerience will take place 13 & 14 September 2023
This year we already host the third edition of the ExciPerience – our event all around excipients, drug delivery and formulation. We make it easily accessible online and free of charge for people from academia and the pharmaceutical industry!
Speaker overview
We already have confirmations from a lot of very interesting and knowledgeable speakers. See the overview here and expect more interesting speakers to be confirmed soon.
KEYNOTE
Prof. Dr. Stephan Haubold“Sustainability – fact or fiction? How to bring sustainability into daily business operations of pharmaceutical companies”
Dr. Atheer Awad“Pharmacy in the digital age”
Dr. Nélio Drumond“Patient centric drug product design”
Laura Pereira Díaz“Machine learning approaches to the prediction of powder flow behaviour of pharmaceutical materials from physical properties”
Prof. Dimitrios A. Lamprou“A Journey into the Wonderful World of Emerging Pharmaceutical & Biopharmaceutical Technologies”
Janeen Skutnik-Wilkinson“Risk approach Excipients” – more details to follow
Karl Vorländer“Tableting of fluidized bed granules containing living microorganisms”
Alex Abramson“Oral Delivery of Biologic Using Microneedle Capsules”
David Tisi“Selecting Excipients for Improved Drug Palatability”
Prof. Ryan F. Donnelly“Microneedles: Tiny structures with big potential”
Prof. Fang Liu and Dr. Norbert Pöllinger“Fluid bed processing of micropellets to overcome swallowing issues – not a dream any more”
Start-up Innovation
Caren Ligthner, Enantios “Chiral Analytics for Drug Development and Quality Assurance”
Prof. Dr. Jörg Huwyler, Galvita “Templated inverted particles (TIP) as a novel pharmaceutical excipient”
Casey Davis, Tablitz “TaBlitz: Globally Revolutionizing Tablet Design”
Jonas Bäck, “OnDosis – Radically simplifying individualized treatments”
More Speakers & Information to follow soon!
Solving capping challenges using mannitol as an excipient model
Webinar recording now available
During drug development formulators are focusing on Improving patient compliance, enhancing production efficiency on top of developing a robust and stable API formulation.
This complex environment could lead to compromising on certain things such as:
- Tablet size and shape
- API loading in the tablet
- Manufacturing speed
The solution we developed, unlocks higher active pharmaceutical ingredient (API) loading, allows smaller tablet intake and faster product output with a lowered risk of tablet capping or instability. In this webinar we will:
- Elaborate about key criteria leading to capping
- How to design an ultimate excipient for direct compression
- Share case studies
Recent Webinar Recordings:
Development of directly compressible formulations of Sitagliptin hydrochloride and Sitagliptin phosphate.
Rational Selection and Application of Ready-to-Use Formulations for Self-Emulsifying Drug Delivery Systems
Glatt:Pellets from fluid bed processes – a smart concept for high(er) potent drug processing
Glatt:Quality Services along the Value Chain
From powder to DC oral solid dosage form – using galenIQ™, the sweet-tasting filler binder.
Solving one of the biggest limitations of modern clinical trials: Patient Recruitment
Downstream Processing with Alexanderwerk & Shin-Etsu
Spray drying with Shin-Etsu, ProCepT and Xedev
Multiparticulates Part 8: Scale up considerations on the Wurster (bottomspray) fluidized bed process
Hot Melt Extrusion (HME) with Shin-Etsu, Leistritz and the St. John’s University
Make it Right: Best Practices for mRNA Manufacturing
Regulatory Considerations Regarding Immediate Release Film Coatings Post-Approval Changes in the U.S and Europe
Multiparticulates 7 – Next Generation ODTS with high dosed Multiparticulates
ZoomLab™: Digitally guiding dosage form and formulation for improved solubility
Multiparticulates – modern oral drug products for our society; Part 6: DoE case studies in QbD development
Don’t Feed the Trolls – Crazy Powders and Electrostatic Charge in Continuous Manufacturing
Multiparticulates 5 – Product and process development applying QbD and DoE concepts to define DS
galenIQ™ – Ask the expert!
Addressing Raw Material Handling Challenges by Dry Granulation
Rx & OTC Product Line Extensions with Oral Lipid-Based Delivery Platforms
Merck: 3D Printing – shaping the future of formulation development
Multiparticulates 4b – Glatt Fluidbed Wurster Drug Layering and Coating – the Process
ZoomLab™ – The interview with Dr. Ferdinand Brandl from BASF
Multiparticulates Part IVa: Functional Coating Applications – The Basics
Understanding the regulatory landscape of Titanium Dioxide, and the impact on tablet filmcoatingsthat are Ti02 free
Ready-to-Use: When Film Coating Becomes Easy, Fast & Reliable
BASF & Catalent: Optimizing Lipid-Based Formulation For Commercial Success
Multiparticulates for paediatric oral drug delivery
Neutral And Functional Starter Pellets
DiCOM SANAQ® – a move forward into direct compression
The Easy Way Of Tableting: Excipient Premixes For Direct Compression
Multiparticulates From Matric Core Pellets – Glatt CPS® Technology
Market Trends &Clean LabelSolutions for Solid Oral Dosage Forms
Multiparticulates As Modern Oral Drug Products
Multiparticulates Part III: Multiparticulates From Matrix Core Pellets – Glatt MicroPx And ProCell Technology
Leveraging Digital Assistance to Address Oral Solid Dosage Formulation Challenges
Innovative Technologies For Amorphous Solid Dispersions
A beginners guide to SELF’ies for solubility and oral bioavailability enhancement
Key to Successful Formulation Development for Lipid Based RNA Delivery and Vaccines